BioPharma

BioPharma has built a portfolio of debt securities and that are collateralized by royalties on drug sales. These debt instruments are secured by royalty payments from top-tier pharmaceutical marketers on drugs, often with several years of sales and a proven track record.

 

Back to Portfolio